Home > Boards > US Listed > Biotechs >

Nabriva Therapeutics AG (NBRV)

NBRV RSS Feed
Add NBRV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/14/2019 7:56:53 PM - Followers: 29 - Board type: Free - Posts Today: 0

Nabriva Therapeutics AG Leberstrasse 20 Vienna, 1110 Austria Phone: 43 1 740 93 0 Fax: 43 1 740 93 1900 Website: http://www.nabriva.com Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which has completed a Phase II clinical trial for acute bacterial skin and skin structure infections. The company is developing intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia; and intends to develop lefamulin for additional indications other than pneumonia. It is also developing BC-7013, a topical pleuromutilin product candidate, which has completed a Phase 1 clinical trial. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics AG in 2007. Nabriva Therapeutics AG was incorporated in 2005 and is headquartered in Vienna, Austria.
NBRV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NBRV News: Nabriva to Present Data at the CHEST Annual Meeting Demonstrating the Safety and Efficacy of Newly FDA-Approved XENLETA (lefa... 10/15/2019 07:00:00 AM
NBRV News: Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 10/01/2019 04:01:00 PM
NBRV News: Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019 10/01/2019 10:07:00 AM
NBRV News: Lefamulin Evaluation Against Pneumonia 2 (LEAP 2) Study Results Published in the Journal of the American Medical Association 09/27/2019 12:15:27 PM
NBRV News: Current Report Filing (8-k) 09/26/2019 04:03:00 PM
PostSubject
#180   Nabriva Therapeutics (nbrv) DorseyE 10/14/19 07:56:53 PM
#179   DUBLIN, Ireland, Sept. 27, 2019 (GLOBE NEWSWIRE) -- runcaly 09/27/19 12:21:43 PM
#178   NABRIVA TO PRESENT DATA FROM XENLETA (LEFAMULIN) AND runcaly 09/26/19 04:26:50 PM
#177   Top Penny Stocks To Watch Making Headlines jonny_red 09/16/19 08:56:59 AM
#176   Do you own this or are you shorting this. Crazyjake27 09/13/19 11:42:34 PM
#175   Troll Crazyjake27 09/13/19 11:41:38 PM
#174   * * $NBRV Video Chart 09-12-2019 * * ClayTrader 09/12/19 05:51:59 PM
#173   * * $NBRV Video Chart 09-09-2019 * * ClayTrader 09/09/19 06:00:06 PM
#172   They had already announced that they would begin nsomniyak 09/09/19 11:30:13 AM
#171   And yet it’s down pre market. Can anyone explain this? net_flyer 09/09/19 09:01:03 AM
#170   Good news, as NBRV will have revenue streaming John-Knee 09/09/19 08:22:56 AM
#169   NABRIVA'S XENLETA(TM) (LEFAMULIN) FOR THE TREATMENT OF COMMUNITY-ACQUIRED runcaly 09/09/19 07:06:39 AM
#168   NABRIVA THERAPEUTICS EARNS $5 MILLION MILESTONE PAYMENT UNDER runcaly 09/06/19 07:05:22 AM
#167   can it kill MRSA? redspinelpinktopaz 08/29/19 09:50:30 AM
#166   * * $NBRV Video Chart 08-20-2019 * * ClayTrader 08/20/19 05:37:10 PM
#164   Notice how these CROOKS(MM) DROPPED THE STOCK PRICE DorseyE 08/20/19 02:45:42 PM
#163   No short sellers! DorseyE 08/20/19 01:21:06 PM
#162   Apparently, the stock is still under Short Sellers John-Knee 08/20/19 10:12:29 AM
#161   takes heavy buying volume for this one to move armxlx 08/20/19 09:23:33 AM
#160   Nabriva Therapeutics' stock soars in heavy volume after DorseyE 08/20/19 09:22:58 AM
#159   Hopefully RDHL WILL BE MY 3rd winner this year!!! DorseyE 08/20/19 01:16:15 AM
#158   HOPEFULLY SOME ANALYST UPGRADES IN THE A.M.!!! DorseyE 08/20/19 01:00:48 AM
#157   First New IV and Oral Antibiotic with a DorseyE 08/19/19 08:33:31 PM
#156   Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta™ DorseyE 08/19/19 08:32:09 PM
#155   Ditto!!! dawsons creek 08/19/19 07:35:42 PM
#154   I will sleep well tonight, anticipating a early DorseyE 08/19/19 06:53:26 PM
#153   FDA approved, tomorrow going to be real fun! dawsons creek 08/19/19 05:16:12 PM
#152   Interesting...what will be the upgraded price target now. Fat Thor 08/19/19 04:19:17 PM
#151   Approved!!!!!! Yes .... ollik78 08/19/19 03:17:15 PM
#150   Will $NBRV received FDA pdufa approval for Lefamulin dontknowsht 08/17/19 06:59:59 PM
#149   [/bNabriva Therapeutics PLC – ADR (NASDAQ: NBRV)]announced, following DorseyE 08/16/19 02:01:31 PM
#148   Is the Options Market Predicting a Spike in DorseyE 08/14/19 03:43:09 PM
#147   Looks like a possible break out homdance 07/31/19 09:35:06 AM
#146   I bought more shares today! DorseyE 07/31/19 02:30:36 AM
#145   On July 25, 2019, pursuant to the terms realfast95 07/25/19 08:42:44 AM
#144   8/19/2019!!! DorseyE 07/22/19 04:07:47 PM
#143   Not a popular board here. Hope that changes soon net_flyer 07/19/19 12:14:31 AM
#142   Ignore my previous post. It was supposed to be Glider549 07/08/19 05:15:08 AM
#140   PROSPECTUS SUPPLEMENT realfast95 06/26/19 09:28:45 AM
#139   $1.72...no news..no filings? WTF bUrRpPPP! 06/10/19 10:56:42 AM
#138   $1.95 yikes! bUrRpPPP! 06/09/19 12:42:17 PM
#137   Just bought more at 2.24 today! DorseyE 05/31/19 02:28:31 PM
#136   Now in at 2150 shares. Hard not to net_flyer 05/23/19 12:51:51 AM
#135   I’m in $272 and waiting. Also in NBRV BUT, net_flyer 05/15/19 11:29:25 AM
#134   Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company realfast95 05/08/19 08:14:48 AM
#133   Anyone notice the nice pop today? Hope this continues. net_flyer 05/06/19 05:45:25 PM
#132   $NBRV upgraded to Hold from Sell at Gabelli. realfast95 05/02/19 06:50:53 PM
#131   * * $NBRV Video Chart 05-01-2019 * * ClayTrader 05/01/19 05:23:09 PM
#130   I think NBRV will adapt and address the PennyWorld 05/01/19 08:55:06 AM
#129   Gabelli's target on the sell was $2.56 realfast95 05/01/19 07:30:21 AM
PostSubject